Inovia Bio Launches Falcon for Drug Development Workflows

Inovia Bio launches Falcon Workflows, an AI system that completes drug development tasks in hours, the company said in a press release. The company says it can configure new AI workers for specific tasks within days.

Falcon drafts clinical study protocols, statistical analysis plans, clinical study reports, target product profiles and clinical development plans. It also handles epidemiological and commercial forecasting, indication prioritization, pipeline analysis and literature reviews.

Inovia Bio says the workflows follow Good Clinical Practice requirements and have undergone automated accuracy and safety tests over two years. Human experts review and approve outputs at designated stages.